Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Asimommy
- Development stage
- Phase 2
- Lead developer
- Universitas Gadjah Mada
- Administration
- Oral
01
Overview
Asimommy is a standardized herbal galactagogue developed by researchers at Universitas Gadjah Mada (UGM) in Indonesia and produced by PT Swayasa Prakarsa. It is a combination product formulated as a capsule containing extracts of *Sauropus androgynus* (Katuk) leaves, *Moringa oleifera* (Kelor) leaves, and *Channa striata* (Snakehead fish). The supplement is designed to enhance breast milk production and improve the nutritional quality of milk in postpartum mothers. *Sauropus androgynus* and *Moringa oleifera* are traditionally recognized for their lactogenic properties, potentially acting through the stimulation of prolactin and oxytocin pathways. The inclusion of *Channa striata* provides high-quality protein and albumin, which aids in maternal postpartum recovery and wound healing. Asimommy has been evaluated in clinical trials to compare its efficacy against pharmacological galactagogues like domperidone.
- Brand names
- ASIMOMMY
- Other names
- Katuk + Kelor + Ikan Gabus extract
02
Targets
PRLR (Prolactin receptor)Oxytocin receptor
Beyond the preview
Go deeper on Asimommy.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Asimommy.